SIRT7 inhibitor 97491 |
Catalog No.GC60338 |
SIRT7 inhibitor 97491, a potent SIRT7 inhibitor with an IC50 of 325 nM, reduces deacetylase activity of SIRT7 in a dose-dependent manner.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1807758-81-1
Sample solution is provided at 25 µL, 10mM.
SIRT7 inhibitor 97491 is a potent SIRT 7 inhibitor that reduces the deacetylase activity of SIRT7 in a dose-dependent manner with an IC50 of 325 nM. SIRT7 inhibitor 97491 increases p53 stability through acetylation at K373/382. In addition, SIRT7 inhibitor 97491 promotes cell apoptosis through the caspase pathway[1].
In vitro, treatment with SIRT7 inhibitor 97491 (5 µM, 10 µM) for 72 hours resulted in a reduction of MES-SA cell proliferation by more than 50% without causing toxic effects on HEK 293 cells[1].
In vivo, three weeks of treatment with SIRT7 inhibitor 97491 (20 mg/kg/day; i.p.) inhibited tumor growth in xenograft mice[1].
References:
[1] Ji-Hye Kim, et al. Identification of a Novel SIRT7 Inhibitor as Anticancer Drug Candidate. Biochem Biophys Res Commun. 2019 Jan 8;508(2):451-457.
Average Rating: 5
(Based on Reviews and 6 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *